e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Slaying the CVD dragon with steroids
Sin D.D., Van Eeden S.F., Man S.F.P.
Source:
Eur Respir J 2010; 36: 466-468
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sin D.D., Van Eeden S.F., Man S.F.P.. Slaying the CVD dragon with steroids. Eur Respir J 2010; 36: 466-468
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Gastro-esophagal reflux and asthma in general practice in Ukraine: can we stop a self-biting dragon?
Source: Eur Respir J 2005; 26: Suppl. 49, 546s
Year: 2005
The impact of cardiovascular drugs in COPD
Source: Annual Congress 2011 - Knowing COPD by heart: a relationship beyond comorbidity
Year: 2011
Effectiveness of treatment with varenicline in smokers with cardiovascular diseases (CVD)
Source: Annual Congress 2009 - Smoking cessation
Year: 2009
Cardiovascular disease and COPD: dangerous liaisons?
Source: Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018
Year: 2018
Drugs for COPD with cardiovascular diseases: Musts and No-go’s
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017
Are patients with respiratory disease deterred from flying?
Source: Eur Respir J 2004; 24: Suppl. 48, 67s
Year: 2004
Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
Source: Eur Respir Rev, 26 (145) 160123; 10.1183/16000617.0123-2016
Year: 2017
Menopause and cardiovascular risk factors in sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 200s
Year: 2006
Using cardioselective beta-blockers in patients with cardiovascular diseases and asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 69s
Year: 2007
Christmas epidemics of exacerbations of COPD: characteristics and risk factors
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events
Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016
Year: 2017
Impact of inhaled corticosteroids in patients with cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 251-263
Year: 2020
Smoking habits in high cardiovascular risk patients
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020
Periodic leg movements as risk factors for hypertension and cardiovascular diseases
Source: Sleep and Breathing Conference 2017
Year: 2017
What affects asthma medicine use in children? Caregiver-related factors
Source: Annual Congress 2010 - PG20 Postgraduate Course: Implementing asthma guidelines for children in daily practice
Year: 2010
The secret life of steroids in asthma
Source: Eur Respir J 2008; 32: 1135-1137
Year: 2008
Late Breaking Abstract - Overuse of oral corticosteroids in asthma – modifiable factors and potential role of biologics
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019
Cardiovascular risk factors: current treatment strategies shaped for the pneumologist
Source: Annual Congress 2012 - COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism?
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept